Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
- PMID: 28535669
- PMCID: PMC5497663
- DOI: 10.3350/cmh.2016.0055
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Abstract
Background/aims: Mongolia has one of the highest hepatitis A, C, B and D infection incidences worldwide. We sought to investigate changes in the proportion of acute viral hepatitis types in Mongolia over the last decade.
Methods: The cohort comprised 546 consecutive patients clinically diagnosed with acute viral hepatitis from January 2012 to December 2014 in Ulaanbaatar Hospital, Mongolia. A time trend analysis investigating the change in proportion of acute hepatitis A virus, hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis delta virus (HDV) infection among the cohort with respect to a previous published study was undertaken.
Results: Acute hepatitis A, B and C was diagnosed in 50.9%, 26.2% and 6.0% of the cohort. Notably, 16.8% of the cohort had a dual infection. The etiologies of acute viral hepatitis were varied by age groups. The most common cause of acute viral hepatitis among 2-19 year olds was hepatitis A, HBV and superinfection with HDV among 20-40 year olds, and HCV among 40-49 year olds. Patients with more than one hepatitis virus infection were significantly older, more likely to be male and had a higher prevalence of all risk factors for disease acquisition. These patients also had more severe liver disease at presentation compared to those with mono-infection.
Conclusions: Acute viral hepatitis is still prevalent in Mongolia. Thus, the need for proper infection control is increasing in this country.
Keywords: Acute hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D.
Conflict of interest statement
Figures


Similar articles
-
Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.J Med Virol. 2006 May;78(5):542-50. doi: 10.1002/jmv.20574. J Med Virol. 2006. PMID: 16555292
-
Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.J Med Virol. 2007 Aug;79(8):1064-74. doi: 10.1002/jmv.20867. J Med Virol. 2007. PMID: 17596839
-
High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.J Med Virol. 2005 Dec;77(4):491-9. doi: 10.1002/jmv.20482. J Med Virol. 2005. PMID: 16254981
-
Recent advances in the hepatitides.Gastroenterol Clin North Am. 1994 Dec;23(4):753-67. Gastroenterol Clin North Am. 1994. PMID: 7698831 Review.
-
Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia.Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):57-62. doi: 10.5005/jp-journals-10018-1260. Epub 2018 May 1. Euroasian J Hepatogastroenterol. 2018. PMID: 29963464 Free PMC article. Review.
Cited by
-
Viral hepatitis among acute hepatitis patients attending tertiary care hospital in central India.Virusdisease. 2019 Sep;30(3):367-372. doi: 10.1007/s13337-019-00541-6. Epub 2019 Jul 26. Virusdisease. 2019. PMID: 31803803 Free PMC article.
-
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic.World J Gastroenterol. 2021 Nov 14;27(42):7271-7284. doi: 10.3748/wjg.v27.i42.7271. World J Gastroenterol. 2021. PMID: 34876788 Free PMC article. Review.
-
The working mechanism of biomarkers related to sumoylation modification in coronary artery disease.Sci Rep. 2025 May 16;15(1):17055. doi: 10.1038/s41598-025-02099-4. Sci Rep. 2025. PMID: 40379803 Free PMC article.
-
The burden of liver cancer in Mongolia from 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Front Oncol. 2024 Sep 3;14:1381173. doi: 10.3389/fonc.2024.1381173. eCollection 2024. Front Oncol. 2024. PMID: 39290241 Free PMC article.
-
The Shifting Epidemiology of Hepatitis A in the World Health Organization Western Pacific Region.Vaccines (Basel). 2024 Feb 16;12(2):204. doi: 10.3390/vaccines12020204. Vaccines (Basel). 2024. PMID: 38400187 Free PMC article. Review.
References
-
- World Health Organization (WHO) Hepatitis B. Fact sheet number 204, revised October 2000. WHO web site, < http://www.who.int/mediacentre/factsheets/fs204_Jul2014/en/>. Accessed 2013.07.06.
-
- World Health Organization (WHO) Hepatitis C. Fact sheet number 164, revised October 2000. WHO web site, < http://www.who.int/mediacentre/factsheets/fs164_apr2014/en/>. Accessed 2013.07.06.
-
- Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int. 2011;31:7–21. - PubMed
-
- Baatarkhuu O, Kim DY, Ahn SH, Nymadawa P, Dahgwahdorj Y, Shagdarsuren M, et al. Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int. 2008;28:1389–1395. - PubMed
-
- World Health Organization (WHO) The Work of WHO in the Western Pacific Region 2003–2004. Report of the Regional Director to the Regional Committee for the Western Pacific, Statistical Annex. Manila: World Health Organization, Regional Office for the Western Pacific; 2003. pp. 190–205.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical